Banning the abortion pill is “scandalous”, for its inventor, Etienne-Emile Baulieu

Last Friday, Wyoming became the first American state to ban the abortion pill, which constitutes a new victory for the conservatives who intend to reduce access to abortion in the United States.

“It is a setback for the freedom of women, especially for the most precarious who will not have the means to go to another State to obtain it.r”. Etienne-Emile Baulieu does not mince his words, he who has devoted a good part of his life to the exact opposite: “increasing the freedom of women”.

Son of a nephrologist who died when he was only 3 years old, raised by his mother, a feminist, he was resistant at 15. This “doctor who does science”, as he likes to define himself, specializes in the study of steroid hormones.

Invited to work in the United States, he was noticed in 1961 by Gregory Pincus, the father of the contraceptive pill, who convinced him to work on sex hormones.

Back in France, he designed an anti-hormone, which opposes the action of progesterone, essential for the implantation of the egg in the uterus. “I wanted to make it a +contragestive+“, he explains to AFP, that is to say a means of countering gestation.

The RU-846 molecule, developed in 1982 with the Roussel-Uclaf laboratory with which it partnered, is a medicinal alternative to surgical abortion, safe and inexpensive.

But the battle for its marketing will be tough, the powerful American anti-abortion leagues accusing it in particular of having invented a “death pill”.

“You, Jew and resistance fighter, have been overwhelmed with the most atrocious insults and have been compared to Nazi scientists (…) But you held on, for the love of freedom and science“, recalled in early March President Emmanuel Macron, presenting him with the Grand Cross of the Legion of Honor.

“Fanaticism and Ignorance”

“Adversity slips off him like water off a duck’s feathers, he’s extremely tough“, says producer Simone Harari Baulieu, who has shared his life for more than 30 years.

This “return” decided in the United States betrays, according to him, “fanaticism and ignorance”.

In his office in Inserm unit 1195 at the Kremlin-Bicêtre University Hospital, which he continues to occupy three times a week, and where photos, diplomas, binders containing “the work of a lifetime” are piled up , or sculptures offered by his friend Niki de Saint-Phalle, he still wants to “be useful”.

If he discreetly wears his recent decoration on his blue suit, he claims to have “never seriously hoped to receive such honors”: “it made me happy but what interests me is to improve the health of folks”.

In his lab, his teams are continuing the research he began years ago to prevent the development of Alzheimer’s disease but also to treat severe depression: a clinical trial in humans is taking place until the end of summer in a dozen university hospitals and at the AP-HP (hospitals of Paris).

“There’s no reason we can’t find treatments“, advances this great optimist. “It feels good to find when you do this job“, he completes, listing his hobbyhorses: “women, brain health, longevity“.

“Always enthusiastic, he is a driving force for us; when he comes we discuss our progress“, book Julien Giustiniani, team leader at the Baulieu Institute, created to finance research on senile dementia.

If he has to use a cane to walk, Etienne-Emile Baulieu seems tireless.

This user of DHEA, a natural hormone which he thinks can delay aging and whose secretion by the adrenal glands he had described in 1963, still goes regularly to attend shows, and admits, with a laughing eye, to be “stimulated by difficult subjects“.

“If I didn’t work anymore, I would be bored I think“, he breathes.